General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Whiteswell(MODEST), Abiomed(SIGNIFICANT), Merck & Co., Inc.(MODEST), Bayer(MODEST), Novo Nordisk Inc.(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Astra Zeneca(MODEST) OTHER FINANCIAL BENEFIT: Zoll(MODEST), HFSA(SIGNIFICANT)
